SCHEMBL3396735

SCHEMBL3396735

Brc1c[c]cc(Br)c1-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
MAPK1 P28482 4/20 0.42
MAPT P10636 2/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
FABP4 P15090 1/20 0.37
TYMP P19971 1/20 0.36
TDP1 Q9NUW8 2/20 0.35
KDM4E B2RXH2 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
ACHE P22303 1/20 0.31
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
AKR1C4 P17516 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27901709 0.82 ALDH1A1 (0.52) ALDH1A1MAPK1MAPTLMNACRHBP
SCHEMBL9649212 0.76 PTGS2 (0.37) ALDH1A1HTTTYMPKDM4EL3MBTL1
SCHEMBL8973903 0.76 ALDH1A1 (0.55) ALDH1A1MAPK1MAPTLMNAHTT
SCHEMBL13319607 0.73 ALDH1A1 (0.50) ALDH1A1MAPK1MAPTLMNAHTT
SCHEMBL27959056 0.72 ALDH1A1 (0.48) ALDH1A1MAPK1MAPTLMNAHTT
SCHEMBL1451086 0.72 LMNA (0.42) ALDH1A1MAPK1MAPTLMNAHTT
SCHEMBL15714371 0.72 ALDH1A1 (0.55) ALDH1A1MAPK1MAPTLMNAHTT
SCHEMBL195477 0.72 ALDH1A1 (0.53) ALDH1A1MAPK1MAPTLMNAHTT
Water SCHEMBL2805294 0.70 ALDH1A1 (0.46) ALDH1A1MAPK1MAPTLMNAHTT
Water SCHEMBL6679536 0.70 ALDH1A1 (0.46) ALDH1A1MAPK1MAPTLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7674909-B2 Biphenyl-4-carboxylic acid {1-acetyl-4-[4-(2-dimethylammo-ethoxy-phenyl]-2,2,4-trimethyl-1,2,3,4-tetrahydro-quinolin-6-yl}-amide; fertility regulation; follicle stimulating hormone (FSH) N.V. ORGANON (NL) 2010-03-09 US disclosed
US-20060167047-A1 Tetrahydorquinoline derivatives and their use as fsh receptor modulators MERCK SHARP & DOHME B.V. (NL) 2006-07-27 US disclosed
EP-1242399-A1 $g(a)-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS UCB S.A. (BE) 2002-09-25 EP disclosed
WO-2001046167-A1 α-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS UCB, S.A. (BE) 2001-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167047-A1 Tetrahydorquinoline derivatives and their use as fsh receptor modulators FSHR, GNRHR, LHCGR ALDH1A1 2019/4885MAPK1 3059/4885MAPT 4751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.